Enanta Pharmaceuticals (ENTA) Q4 2023 Earnings

7FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-2.33
-1.96
-1.59
-1.23

Details

Expected EPS
-1.226
Actual EPS
-1.58
Surprise EPS
-0.35
Surprise Percent
+28.87%

Description

Enanta Pharmaceuticals (ENTA) has reported earnings of -1.58 per share for Q4 2023.

0 Comments

Share your thoughts